certolizumab
ucb pharmaceuticals
['certolizumab', 'axspa']
 abs 0543 rudwaleit, al. post-hoc analysis of rapid-axspa (certolizumab) : is there a disconnect between composite measures (response criteria used in trials) and inflammation (crp, mri)? #acr22
@bu_bmc_rheum | @rheum_covid @spartan_updates @official_asas | @UWRheum @UWEpidemiology 2020 | @OHSUIMres 2017 | @UTMBhealth 2014 | @UTAustin 2010